Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04438083
Title A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors CRISPR Therapeutics AG

renal cell carcinoma



Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Research Site 2 Recruiting Duarte California 91010 United States Details
Research Site 5 Recruiting Hartford Connecticut 06520 United States Details
Research Site 4 Recruiting Houston Texas 77030 United States Details
Research Site 3 Recruiting Salt Lake City Utah 84112 United States Details
Research Site 1 Recruiting Melbourne Victoria 3000 Australia Details
Research Site 6 Recruiting Toronto Ontario M5G 2M9 Canada Details
Research Site 7 Recruiting Amsterdam North Holland 1066 Netherlands Details
*Shaded cells indicate that there was no data available from for the field